K. Yuki, M. Fujiogi, and S. Koutsogiannaki, COVID-19 pathophysiology: A review, Clin. Immunol, vol.215, p.108427, 2020.

F. Raucci, A. A. Mansour, G. M. Casillo, A. Saviano, F. Caso et al., Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms, Autoimmun. Rev, p.102572, 2020.

N. Tang, H. Bai, X. Chen, J. Gong, D. Li et al., Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy, J. Thromb. Haemost, 2020.

C. A. Frazer, Heparin-Induced Thrombocytopenia, J. Infus. Nurs, vol.40, pp.98-100, 2017.

M. Cattaneo, P2Y 12 receptors: structure and function, J. Thromb. Haemost, vol.13, pp.10-16, 2015.

K. F. Alsharif, M. R. Thomas, H. M. Judge, H. Khan, L. R. Prince et al., Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis, Vascul. Pharmacol, vol.71, pp.201-207, 2015.


R. F. Storey, S. K. James, A. Siegbahn, C. Varenhorst, C. Held et al., Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study, Platelets, vol.25, pp.517-525, 2014.

M. Rahman, D. Gustafsson, Y. Wang, H. Thorlacius, and O. Ö. Braun, Ticagrelor reduces neutrophil recruitment and lung damage in abdominal sepsis, Platelets, vol.25, pp.257-263, 2014.

T. R. Sexton, G. Zhang, T. E. Macaulay, L. A. Callahan, R. Charnigo et al.,

Z. Vsevolozhskaya, S. Li, and . Smyth, Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia, JACC Basic Transl. Sci, vol.3, pp.435-449, 2018.


M. R. Thomas, S. N. Outteridge, R. A. Ajjan, F. Phoenix, G. K. Sangha et al., Platelet P2Y, p.12

, Inhibitors Reduce Systemic Inflammation and Its Prothrombotic Effects in an Experimenta l Human Model, Arterioscler. Thromb. Vasc. Biol, vol.35, pp.2562-2570, 2015.


L. Traby, M. Kollars, A. Kaider, J. M. Siller-matula, M. F. Wolkersdorfer et al., Differential Effects of Ticagrelor With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers, Clin. Pharmacol. Ther, vol.107, pp.415-422, 2020.

S. K. Parasuraman, A. I. Teo, C. G. Millar, and A. Noman, Pneumonitis and pulmonar y haemorrhage after acute myocardial infarction, Clin. Med. Lond. Engl, vol.15, pp.591-593, 2015.

M. Tomaniak, P. Chichareon, Y. Onuma, E. N. Deliargyris, K. Takahashi et al., for the GLOBAL LEADERS Trial Investigators, Benefit and Risks of Aspirin in Addition to Ticagrelor in Acute Coronary Syndromes: A Post Hoc Analysis of the Randomized GLOBAL LEADERS Trial, vol.4, p.1092, 2019.


C. Lai, T. Shih, W. Ko, H. Tang, and P. Hsueh, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges, Int. J. Antimicrob. Agents, vol.55, p.105924, 2020.

A. Z. Zucoloto and C. N. Jenne, Platelet-Neutrophil Interplay: Insights Into Neutrophil Extracellular Trap (NET)-Driven Coagulation in Infection, Front. Cardiovasc. Med, vol.6, 2019.